ECRI Institute has unveiled a list of 10 emerging innovations healthcare leaders should watch this year. A neonatal MRI system, direct-to-consumer genetic testing and VR for pediatric patients are among the topics that made the cut.
Just 10 percent of women with a family history of breast cancer test positive for one of the 11 genes directly associated with disease risk. Myriad’s new riskScore assessment caters to the other 90 percent.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Celexa. Zoloft. Prozac. Lexapro. Cymbalta. The list of FDA-approved drugs to treat depression and other neuropsychiatric disorders goes on and on. Finding the right one, or ones, for a patient is often a matter of guesswork, said James Burns, CEO of personalized medicine company Assurex Health (formerly AssureRx). “It’s usually ‘start low and go slow,’” […]
Felix Frueh says that patients are not the barrier to wide use of genetic tests. In a discussion of personalized medicine at CONVERGE, he said that he has absolute confidence in the willingness of patients to participate. He described a Medco program that connected doctors and patients with genetic tests. Doctors and patients were both […]
The Supreme Court ruled yesterday that companies could not patent human genes. This case focused on the BRCA 1 and 2 genes linked to breast cancer risk, but the U.S. Patent Office has issued patents on thousands of human genes, including genes associated with colon cancer, Alzheimer’s disease, and muscular dystrophy. The unanimous decision was […]
When a company sets out to enter a market inhabited by heavyweights like LabCorp and Quest Diagnostics, it better have something good. Good Start Genetics has applied next-generation DNA sequencing to existing knowledge and testing methods to come up with what it thinks is that something special. The company has developed a series of […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Angeline Jolie’s disclosure of her double mastectomy has drawn the mainstream media’s attention to genetic testing, a recent medical advancement with huge, albeit challenging, implications. Many experts predict that genetic testing is on its way to becoming a routine part of clinical care. Already, genomic tests have been developed for more than 2,200 diseases — […]
Between three and five new genetic tests are introduced to the market each month, UnitedHealth Group told us in a report last May. While that may sound like a great step toward more data-driven, personalized medicine, integrating these tests into clinical practice has actually left many physicians scratching their heads.